Obesity confers increased risk for various forms of cancer. Breast, colon, and liver cancer are all increased in obese populations and the epidemiologic evidence for the obesity - breast cancer connection is compelling. One in eight women will be diagnosed with breast cancer during her lifetime. Breast cancer is strongly associated with age as incidence increases 10-fold for women age 260 compared to women age S50. Increased risk with age seems related to post-menopausal hormone levels as both obesity and hyperinsulinemia are associated with increased breast cancer risk only in women not on hormone replacement therapy. Metabolic Syndrome is associated with a higher incidence of aggressive triple negative breast tumors (ER-/PR-/HER2-) which is likely accelerated by ovarian hormone decline after menopause, as post-menopausal women are more susceptible to the deleterious metabolic effects of obesity including chronic inflammation and insulin resistance. Rodent studies have confirmed this relationship, showing that diet-induced obesity and high fat diets lead to increased incidence and growth of tumors in various breast cancer models. Despite this body of correlative evidence, the mechanisms of obesity-induced breast cancer risk remain poorly understood. Diet composition is an important factor as diets rich in saturated and omega 6 (w6) fatty acids (FAs) are pro-inflammatory and increase breast cancer risk, but diets rich in omega 3 (w3) FAs are anti-inflammatory and decrease cancer risk. The clinical data is less clear but meta-analyses of multiple human breast cancer risk studies suggest that the ratio of oo6 to w3 FAs is a critical factor. We have found that the beneficial anti-inflammatory and insulin-sensitizing effects of 0)3 FAs are mediated by the G-protein coupled receptor GPR120. Due to the potential link between obesity, insulin resistance and breast cancer risk in post-menopausal women, we hypothesize that GPR120 is the critical mediator of the protective effects of w3 FAs in breast cancer. We will test this in four specific aims that combine 1) studies using orthotopic tumor cell transplants and 2) spontaneous tumors in obese wild type (WT) and GPR120 knockout (KO) mice, ? w3 FA supplementation, 3) studies using orthotopic mouse and human tumor cell transplants into RAG2 KO mice, and 4) studies of metastasis using genetically marked tumor cells in obese WT and GPR120 KO mice. We hypothesize that u)3 FAs will attenuate tumorigenesis and metastasis in WT but not GPR120 KO mice through their anti-inflammatory/insulin-sensitizing actions This project aims to provide mechanistic depth that is complementary to aims of Projects 2 &3.

Public Health Relevance

Obesity is a strong risk factor for breast cancer in post-menopausal women because as ovarian hormones decline, women are less protected from the harmful effects of obesity, including inflammation and increased insulin levels. The omega 3 fatty acids in fish oil protect against ttie adverse effects of obesity through a specific cell surface receptor called GPR120. This proposal will test whether omega 3 fatty acids will also protect against breast cancer through this same receptor

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA155435-04
Application #
8688936
Study Section
Special Emphasis Panel (ZCA1-SRLB-4)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
4
Fiscal Year
2014
Total Cost
$225,924
Indirect Cost
$64,574
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Full, Kelsie M; Kerr, Jacqueline; Grandner, Michael A et al. (2018) Validation of a physical activity accelerometer device worn on the hip and wrist against polysomnography. Sleep Health 4:209-216
Quante, Mirja; Mariani, Sara; Weng, Jia et al. (2018) Zeitgebers and their association with rest-activity patterns. Chronobiol Int :1-11
Rana, Brinda K; Flatt, Shirley W; Health, Dennis D et al. (2017) The IL-6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention. Nutrients 9:
Hartman, Sheri J; Marinac, Catherine R; Bellettiere, John et al. (2017) Objectively measured sedentary behavior and quality of life among survivors of early stage breast cancer. Support Care Cancer 25:2495-2503
Patterson, Ruth E; Sears, Dorothy D (2017) Metabolic Effects of Intermittent Fasting. Annu Rev Nutr 37:371-393
James, Peter; Hart, Jaime E; Hipp, J Aaron et al. (2017) GPS-Based Exposure to Greenness and Walkability and Accelerometry-Based Physical Activity. Cancer Epidemiol Biomarkers Prev 26:525-532
Fernandez, Marina O; Sharma, Shweta; Kim, Sun et al. (2017) Obese Neuronal PPAR? Knockout Mice Are Leptin Sensitive but Show Impaired Glucose Tolerance and Fertility. Endocrinology 158:121-133
Mendoza, Jason A; Haaland, Wren; Jacobs, Maya et al. (2017) Bicycle Trains, Cycling, and Physical Activity: A Pilot Cluster RCT. Am J Prev Med 53:481-489
Kerr, Jacqueline; Marinac, Catherine R; Ellis, Katherine et al. (2017) Comparison of Accelerometry Methods for Estimating Physical Activity. Med Sci Sports Exerc 49:617-624
Mitchell, Jonathan A; Quante, Mirja; Godbole, Suneeta et al. (2017) Variation in actigraphy-estimated rest-activity patterns by demographic factors. Chronobiol Int 34:1042-1056

Showing the most recent 10 out of 46 publications